HIT Consultant June 30, 2022
Kelly Patrick, Principal Analyst at Signify Research

Like most healthcare markets, the diagnostic cardiology market has had a bumpy ride in recent years. The COVID-19 pandemic saw global revenues for Resting ECG devices increase in 2020, whilst ECG Management Systems, Stress ECG and Traditional Holter ECG solutions saw a market decline. Country lockdowns resulted in reduced cardiology services during the peak of the pandemic, as non-urgent appointments were delayed. 2021 showed relief for cardiac facilities as providers started to deal with the patient backlog and demand returned for all solutions to above the levels seen in 2019.

The future of diagnostic cardiology

Healthcare facilities are now having to rethink the way in which care is provided, with many providers increasing their pace in the transition to digital...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Medical Devices, Physician, Provider
Bruker to acquire Nanostring for $393M
Abbott's gains in medical device sales push quarterly haul to nearly $10B
Abbott looks to ‘highly productive’ device pipeline for future growth
Scopio Labs Receives FDA Clearance For AI-Driven Bone Marrow Analysis Application
10 notes on colonoscopies in 2024

Share This Article